Urinary trypsin inhibitor attenuates liver enzyme elevation after liver resection

BACKGROUND: Urinary trypsin inhibitors (UTI) have been widely used for the treatment of diseases including disseminated intravascular coagulation, shock, and pancreatitis. Since UTI synthesis is likely to be reduced in patients who have undergone liver resection, the incidence of inflammatory reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Cheol-Won, Lee, Cha-Sup, Lee, Seong-Heon, Jeung, Hye Jin, Kwak, Sang-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Anesthesiologists 2012
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427803/
https://www.ncbi.nlm.nih.gov/pubmed/22949978
http://dx.doi.org/10.4097/kjae.2012.63.2.120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427803/
https://www.ncbi.nlm.nih.gov/pubmed/22949978
http://dx.doi.org/10.4097/kjae.2012.63.2.120

Ejemplares similares